Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Rio de Janeiro; s.n; 2008. 96 p. ilus, graf.
Thesis in Portuguese | LILACS | ID: lil-488496

ABSTRACT

Nutrientes específicos, denominados farmaconutrientes, demonstraram possuir a capacidade de modular a resposta imunológica e inflamatória de animais e seres humanos, em estudos clínicos e laboratoriais. Dentre os substratos conhecidos, os que têm maior relevância e açãoimunomoduladora são a arginina, glutamina, ácido graxo n-3 e nucleotídeos. No entanto, revisõessistemáticas e meta-análises buscam consenso em relação aos vários e controversos resultados publicados sobre os possíveis benefícios da imunonutrição em pacientes críticos. Objetiva avaliar a efetividade das dietas enriquecidas com Imunonutrientes na redução de complicações e mortalidade nos diferentes tipos de pacientes críticos. O presente estudo é umarevisão sistemática com metanálise onde foram inseridos ensaios clínicos randomizados avaliando o uso de nutrientes imunomoduladores em doente adulto de ambos os sexos, definido como crítico traumatizado, séptico, queimado ou cirúrgico; as dietas utilizadas deveriam conter um ou mais dosimunonutrientes, em qualquer dose, administradas por via enteral comparadas à dieta padrão pelamesma via em pelo menos um dos grupos de comparação. As bases de dados consultadas foram Pubmed e Cinhal, utilizando os termos: Immunonutrition, arginine, glutamine, n-3, nucleotides e criticall illness...


Subject(s)
Humans , Male , Female , Adult , Diet Surveys , Clinical Trials as Topic/methods , Meta-Analysis , Nutritional Sciences/ethnology , Patients/statistics & numerical data , Patients/psychology , Arginine/antagonists & inhibitors , Arginine/blood , Glutamine/physiology , Glutamine/blood , Nucleotides , Nutrition for Vulnerable Groups , Nucleotides/physiology , Nucleotides/blood
2.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;34(6): 825-8, Jun. 2001. graf, ilus
Article in English | LILACS | ID: lil-285860

ABSTRACT

In rats, the nitric oxide (NO)-synthase pathway is present in skeletal muscle, vascular smooth muscle, and motor nerve terminals. Effects of NO were previously studied in rat neuromuscular preparations receiving low (0.2 Hz) or high (200 Hz) frequencies of stimulation. The latter frequency has always induced tetanic fade. However, in these previous studies we did not determine whether NO facilitates or impairs the neuromuscular transmission in preparations indirectly stimulated at frequencies which facilitate neuromuscular transmission. Thus, the present study was carried out to examine the effects of NO in rat neuromuscular preparations indirectly stimulated at 5 and 50 Hz. The amplitude of muscular contraction observed at the end (B) of a 10-s stimulation was taken as the ratio (R) of that obtained at the start (A) (R = B/A). S-nitroso-N-acetylpenicillamine (200 µM), superoxide dismutase (78 U/ml) and L-arginine (4.7 mM), but not D-arginine (4.7-9.4 mM), produced an increase in R (facilitation of neurotransmission) at 5 Hz. However, reduction in the R value (fade of transmission) was observed at 50 Hz. N G-nitro-L-arginine (8.0 mM) antagonized both the facilitatory and inhibitory effects of L-arginine (4.7 mM). The results suggest that NO may modulate the release of acetylcholine by motor nerve terminals.


Subject(s)
Animals , Rats , Arginine/pharmacology , Diaphragm/drug effects , Muscle Contraction/drug effects , Phrenic Nerve , Synaptic Transmission , Acetylcholine/metabolism , Arginine/antagonists & inhibitors , Electric Stimulation , Free Radical Scavengers/pharmacology , Nitric Oxide Donors/pharmacology , Nitric Oxide/pharmacology , Penicillamine/analogs & derivatives , Rats, Wistar , Superoxide Dismutase/pharmacology
3.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;34(4): 549-52, Apr. 2001. graf
Article in English | LILACS | ID: lil-282622

ABSTRACT

Nitric oxide (NO)-synthase is present in diaphragm, phrenic nerve and vascular smooth muscle. It has been shown that the NO precursor L-arginine (L-Arg) at the presynaptic level increases the amplitude of muscular contraction (AMC) and induces tetanic fade when the muscle is indirectly stimulated at low and high frequencies, respectively. However, the precursor in muscle reduces AMC and maximal tetanic fade when the preparations are stimulated directly. In the present study the importance of NO synthesized in different tissues for the L-Arg-induced neuromuscular effects was investigated. Hemoglobin (50 nM) did not produce any neuromuscular effect, but antagonized the increase in AMC and tetanic fade induced by L-Arg (9.4 mM) in rat phrenic nerve-diaphragm preparations. D-Arg (9.4 mM) did not produce any effect when preparations were stimulated indirectly at low or high frequency. Hemoglobin did not inhibit the decrease of AMC or the reduction in maximal tetanic tension induced by L-Arg in preparations previously paralyzed with d-tubocurarine and directly stimulated. Since only the presynaptic effects induced by L-Arg were antagonized by hemoglobin, the present results suggest that NO synthesized in muscle acts on nerve and skeletal muscle. Nevertheless, NO produced in nerve and vascular smooth muscle does not seem to act on skeletal muscle


Subject(s)
Animals , Male , Female , Rats , Arginine/antagonists & inhibitors , Hemoglobins/pharmacology , Muscle Contraction/drug effects , Nitric Oxide/antagonists & inhibitors , Arginine/pharmacology , Diaphragm/drug effects , Diaphragm/metabolism , Electric Stimulation , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/metabolism , Nitric Oxide/biosynthesis , Nitric Oxide/pharmacology , Phrenic Nerve/drug effects , Phrenic Nerve/metabolism , Rats, Wistar
4.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;32(10): 1277-83, Oct. 1999. graf
Article in English | LILACS | ID: lil-252279

ABSTRACT

Although it has been demonstrated that nitric oxide (NO) released from sodium nitrite induces tetanic fade in the cat neuromuscular preparations, the effect of L-arginine on tetanic fade and its origin induced by NO have not been studied in these preparations. Furthermore, atropine reduces tetanic fade induced by several cholinergic and anticholinergic drugs in these preparations, whose mechanism is suggested to be mediated by the interaction of acetylcholine with inhibitory presynaptic muscarinic receptors. The present study was conducted in cats to determine the effects of L-arginine alone or after pretreatment with atropine or 1H-[1,2,4]oxadiazole [4,3-a]quinoxalin-1-one (ODQ) on neuromuscular preparations indirectly stimulated at high frequency. Drugs were injected into the middle genicular artery. L-arginine (2 mg/kg) and S-nitroso-N-acetylpenicillamine (SNAP; 16 µg/kg) induced tetanic fade. The Nw-nitro-L-arginine (L-NOARG; 2 mg/kg) alone did not produce any effect, but reduced the tetanic fade induced by L-arginine. D-arginine (2 mg/kg) did not induce changes in tetanic fade. The tetanic fade induced by L-arginine or SNAP was reduced by previous injection of atropine (1.0 µg/kg) or ODQ (15 µg/kg). ODQ alone did not change tetanic fade. The data suggest that the NO-synthase-GC pathway participates in the L-arginine-induced tetanic fade in cat neuromuscular preparations. The tetanic fade induced by L-arginine probably depends on the action of NO at the presynaptic level. NO may stimulate guanylate cyclase increasing acetylcholine release and thereby stimulating presynaptic muscarinic receptors


Subject(s)
Cats , Animals , Female , Arginine/antagonists & inhibitors , Atropine/pharmacology , Guanylate Cyclase/antagonists & inhibitors , Muscle, Skeletal/metabolism , Nitric Oxide/metabolism , Oxadiazoles/pharmacology , Receptors, Muscarinic/metabolism , Tetanus/chemically induced
5.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;26(8): 853-7, Ago. 1993. tab
Article in English | LILACS | ID: lil-148757

ABSTRACT

We examined whether nitric oxide mediates estrogen-induced uterine edema in the immature rat. Immature Wistar rats (19-21 days) received estradiol-17 beta (E2) in a single sc dose of 10 micrograms/animal and 6 h later the animals were sacrificed and the changes in uterine wet and dry weights were determined. E2 treatment caused a 93 per cent increase in uterine wet weight (control, N = 6, 39.88 +/- 3.2 mg; E2 treated, N = 6, 76.8 +/- 4.9 mg), but not in dry weight, suggesting that it induces uterine edema. Pretreatment with L-nitroarginine methyl ester (L-NAME), a competitive antagonist of nitric oxide synthetase, at doses of 10 and 20 mg/kg, ip, caused a dose-related reduction (59 and 86 per cent ) in the uterine wet weight increase induced by E2. Furthermore, L-arginine (300-600 mg/kg, sc), the nitric oxide precursor, was able to reverse L-NAME (20 mg/kg)-induced decreases in uterine weight by 47 and 62 per cent , respectively. The results suggest that nitric oxide is the principal mediator involved in estrogen-induced uterine edema in the immature rat


Subject(s)
Animals , Female , Rats , Uterine Diseases/chemically induced , Edema/chemically induced , Nitric Oxide/physiology , Amino Acid Oxidoreductases/antagonists & inhibitors , Arginine/analogs & derivatives , Arginine/antagonists & inhibitors , Arginine/pharmacology , Uterine Diseases/metabolism , Uterine Diseases/pathology , Edema/metabolism , Edema/pathology , Enkephalin, Leucine-2-Alanine/analogs & derivatives , Enkephalin, Leucine-2-Alanine/pharmacology , Estradiol/administration & dosage , Organ Size , Rats, Wistar , Uterus
SELECTION OF CITATIONS
SEARCH DETAIL